SCHEMBL30723280

SCHEMBL30723280

Oc1cnc(O)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.50
ERN1 O75460 1/20 0.42
EP300 Q09472 2/20 0.39
KAT2B Q92831 2/20 0.39
KAT8 Q9H7Z6 2/20 0.39
HDAC3 O15379 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
TRPM4 Q8TD43 1/20 0.39
CYP1A2 P05177 1/20 0.37
LMNA P02545 4/20 0.37
HTT P42858 2/20 0.37
KDM4E B2RXH2 4/20 0.36
NPC1 O15118 2/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CA12 O43570 1/20 0.36
GMNN O75496 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10642216 1.00 IDO1 (0.50) IDO1ERN1EP300KAT2BKAT8
SCHEMBL29941311 0.78 IDO1 (0.48) IDO1ERN1EP300KAT2BKAT8
SCHEMBL1315474 0.78 IDO1 (0.48) IDO1ERN1EP300KAT2BKAT8
SCHEMBL5398756 0.76 PLAU (0.52) IDO1CYP1A2LMNAHTTKDM4E
SCHEMBL1445945 0.76 PLAU (0.52) IDO1ERN1HTTKDM4EMAPT
SCHEMBL1133886 0.76 KDM4E (0.48) IDO1ERN1EP300KAT2BKAT8
SCHEMBL1133874 0.76 IDO1 (0.46) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL12804693 0.76 ALDH1A1 (0.52) IDO1CYP1A2LMNAHTTKDM4E
SCHEMBL1563993 0.76 IDO1 (0.46) IDO1ERN1EP300KAT2BKAT8
SCHEMBL19725154 0.76 IDO1 (0.35) IDO1ERN1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079889-A Synthetic method of isoquinoline 2026-05-26 CN disclosed
CN-117486797-A Key intermediate of roflumilast and preparation method of roflumilast 传健生物医药(厦门)有限公司 2024-02-02 CN disclosed